New Preoperative Regimen Gets a Win in Pancreatic Cancer

(MedPage Today) — CHICAGO — A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and gemcitabine (PAXG) topped a standard option in a randomized trial of resectable or borderline resectable…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115854

Author :

Publish date : 2025-06-02 16:57:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

New Preoperative Regimen Gets a Win in Pancreatic Cancer

Deep Cuts Erode Public Health’s Foundation, End Progress, Threaten Worse to Come

From ’10/10′ Pain to ’10/10′ Healthcare

Related Posts

Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Premature babies in UK to be immunised against winter virus RSV

FDA Advisors Give PTSD Drug Combination a Thumbs Down

Researchers Detail Alarming Rise in GI Cancers Among Young People

Surgery, Ablation Lead to Similar Outcomes for Small Liver Tumors

What Are the Health Impacts of the $9 Billion Rescissions Package?

Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Premature babies in UK to be immunised against winter virus RSV

FDA Advisors Give PTSD Drug Combination a Thumbs Down

Researchers Detail Alarming Rise in GI Cancers Among Young People

Surgery, Ablation Lead to Similar Outcomes for Small Liver Tumors

What Are the Health Impacts of the $9 Billion Rescissions Package?

Trump’s Chronic Venous Insufficiency: What to Know About the Common Condition

Remove Boxed Warning on Hormone Therapy for Menopause, FDA Panel Says

Categories

Archives